Thalamic Glioma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-12-24
Clinical Trial Update: Oral ONC201 in Adult Recurrent Glioblastoma [Phase 2]
Phase 2 trial of oral ONC201 in adult recurrent glioblastoma was terminated; results have been posted.